Exosens Shares Dip Nearly 3% After Year-Long Surge
The French specialist in night vision and imaging technologies for defense takes a breather after a sustained upward trend. The stock falls in mid-afternoon, while the underlying momentum remains strong over the year. The decline follows just after crossing a closely watched technical threshold last week.
A Consolidation After a Week of Strong Gains in Defense
Exosens falls by 2.64% to €66.35 in mid-afternoon trading, following a previous close at €68.15. The stock is among the steepest declines in the SBF 120, while the broader index is up by 0.29%.
This drop comes after a session that saw the stock break its resistance at €66.65, following several industrial announcements. The night vision specialist notably announced its integration into the European SPIRIT project on infrared detection, and confirmed the doubling of its production capacity for cooled infrared cameras by 2026. The recent weeks had pushed the stock close to its peaks, so a profit-taking after this rally is not surprising. The performance over one year remains solid at over 53%, and the gain over three months is at 6.5%.
The Price Maintains a Significant Cushion Above All Moving Averages
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Today's decline leaves the stock in a still favorable technical configuration. The price remains above the MM20 at €62.21 (a gap of 6.65%), the MM50 at €63.45 (a gap of 4.57%) and well above the MM200 at €52.66, a gap of 26%. The RSI at 61 remains in the neutral zone, with no immediate exhaustion signal despite the recent rise.
The support at €56.45 is below the short moving averages, which leaves room for maneuver before a technical test. The immediate resistance, identified at €69.20, is now within reach and had served as a ceiling last week. The sectoral context remains supportive for European defense stocks, with Brent crude moving back above $93 amid tensions in the Middle East. The €69.20 zone will be the next technical threshold to watch to gauge the stock's ability to resume its upward trajectory.
Porté par une dynamique commerciale soutenue, en particulier sur les marchés de la Défense et de la Surveillance, ainsi que par une solide exécution opérationnelle
Risks mentioned
Charge de dépréciation de la marque de 28,2 M€ pesant sur le résultat net publié, en baisse de 45,0 %
Incertitudes persistantes sur la recherche scientifique pesant sur la demande en Sciences de la Vie
Contraction de 60 points de base de la marge brute du segment Détection & Imagerie (mix produits)
Opportunities identified
Attribution par l'US Army du contrat IDIQ BiNOD ouvrant le marché américain de la défense
Plan d'expansion de +40 % des capacités de production d'ici 2027, premiers bénéfices au S2 2026
Acquisition d'Emberion, capteurs infrarouges SWIR à points quantiques
Outlook / guidance
Expected revenue: 530 millions d'euros
Expected EBITDA: 173 millions d'euros
Management commentary: chiffre d'affaires compris entre 520 millions d'euros et 540 millions d'euros ; • EBITDA ajusté compris entre 168 millions d'euros et 178 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
